Brinker Capital Investments, LLC Bluebird Bio, Inc. Transaction History

Brinker Capital Investments, LLC

  • $5.01 Billion
  • Q4 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$16.59 - $33.89 $374,403 - $764,829
-22,568 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$27.5 - $37.92 $288,860 - $398,311
10,504 Added 87.07%
22,568 $977,000
Q3 2020

Dec 03, 2020
BUY
$34.44 - $43.75 $415,484 - $527,800
12,064 New
12,064 $651,000

Others Institutions Holding BLUE

# of Institutions
149
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $652M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Brinker Capital Investments, LLC Portfolio

Follow Brinker Capital Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email